Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
Mariana X Byndloss,Erin E Olsan,Fabian Rivera-Chávez,Connor R Tiffany,Stephanie A Cevallos,Kristen L Lokken,Teresa P Torres,Austin J Byndloss,Franziska Faber,Yandong Gao,Yael Litvak,Christopher A Lopez,Gege Xu,Eleonora Napoli,Cecilia Giulivi,Renée M Tsolis,Alexander Revzin,Carlito B Lebrilla,Andreas J Bäumler,Mariana X. Byndloss,Erin E. Olsan,Connor R. Tiffany,Stephanie A. Cevallos,Kristen L. Lokken,Teresa P. Torres,Austin J. Byndloss,Christopher A. Lopez,Renée M. Tsolis,Carlito B. Lebrilla,Andreas J. Bäumler
DOI: https://doi.org/10.1126/science.aam9949
IF: 56.9
2017-08-10
Science
Abstract:Perturbation of the gut-associated microbial community may underlie many human illnesses, but the mechanisms that maintain homeostasis are poorly understood. We found that the depletion of butyrate-producing microbes by antibiotic treatment reduced epithelial signaling through the intracellular butyrate sensor peroxisome proliferator-activated receptor γ (PPAR-γ). Nitrate levels increased in the colonic lumen because epithelial expression of Nos2, the gene encoding inducible nitric oxide synthase, was elevated in the absence of PPAR-γ signaling. Microbiota-induced PPAR-γ signaling also limits the luminal bioavailability of oxygen by driving the energy metabolism of colonic epithelial cells (colonocytes) toward β-oxidation. Therefore, microbiota-activated PPAR-γ signaling is a homeostatic pathway that prevents a dysbiotic expansion of potentially pathogenic Escherichia and Salmonella by reducing the bioavailability of respiratory electron acceptors to Enterobacteriaceae in the lumen of the colon.
multidisciplinary sciences